ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine


Ulker M., Duman B. B. , ŞAHİN B. , GÜMÜRDÜLÜ D.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, vol.19, no.3, pp.207-213, 2015 (Journal Indexed in ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.5114/wo.2015.52656
  • Title of Journal : WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
  • Page Numbers: pp.207-213

Abstract

Background: We aimed to investigate the impact of RRM1 and ERCC1 expression on response to cisplatin and/or gemcitabine chemotherapy in patients with lung, ovarian or pancreatic cancer.